We are live on ! Find out more
SRPT icon

Sarepta Therapeutics

151 hedge funds and large institutions have $1.1B invested in Sarepta Therapeutics in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 38 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

85% more call options, than puts

Call options by funds: $184M | Put options by funds: $99.4M

76% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 38

23% more capital invested

Capital invested by funds: $891M → $1.1B (+$209M)

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

1% more funds holding

Funds holding: 149151 (+2)

Holders
151
Holders Change
+2
Holders Change %
+1.34%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
22
Increased
67
Reduced
38
Closed
19
Calls
$184M
Puts
$99.4M
Net Calls
+$84.8M
Net Calls Change
+$44.9M
Name Holding Trade Value Shares
Change
Change in
Stake
BA
51
BlackRock Advisors
Delaware
$2.25M -$19M -586,557 -91%
Capital Fund Management (CFM)
52
Capital Fund Management (CFM)
France
$2.19M +$477K +14,707 +35%
FAM
53
Fred Alger Management
New York
$2.16M -$272K -8,400 -13%
Creative Planning
54
Creative Planning
Kansas
$2.04M +$840K +25,900 +96%
BCA
55
Benchmark Capital Advisors
New York
$2M -$25.9K -800 -2%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$1.84M +$214K +6,615 +16%
CIBC World Market
57
CIBC World Market
Ontario, Canada
$1.75M -$116K -3,565 -7%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$1.73M +$172K +5,300 +13%
ProShare Advisors
59
ProShare Advisors
Maryland
$1.66M +$237K +7,301 +20%
CG
60
Cutler Group
California
$1.62M +$1.36M +42,074 New
Citigroup
61
Citigroup
New York
$1.61M +$418K +12,906 +45%
LFR
62
Lehman Financial Resources
Pennsylvania
$1.59M
Wells Fargo
63
Wells Fargo
California
$1.56M -$3.56M -109,882 -73%
GAMA
64
Graticule Asia Macro Advisors
New York
$1.5M +$1.26M +39,000 New
Bank of America
65
Bank of America
North Carolina
$1.49M +$708K +21,849 +130%
Macquarie Group
66
Macquarie Group
Australia
$1.49M -$671K -20,708 -35%
State Board of Administration of Florida Retirement System
67
State Board of Administration of Florida Retirement System
Florida
$1.37M -$214K -6,585 -16%
AQR Capital Management
68
AQR Capital Management
Connecticut
$1.24M +$490K +15,125 +89%
BBHC
69
Brown Brothers Harriman & Co
New York
$1.24M
MLICM
70
Metropolitan Life Insurance Company (MetLife)
New York
$1.23M +$92.1K +2,842 +10%
T. Rowe Price Associates
71
T. Rowe Price Associates
Maryland
$1.22M +$3.89K +120 +0.4%
AIG
72
American International Group
New York
$1.21M +$84.2K +2,598 +9%
UCFA
73
United Capital Financial Advisors
Texas
$1.16M
American Century Companies
74
American Century Companies
Missouri
$1.16M -$659K -20,321 -40%
NFA
75
Nationwide Fund Advisors
Ohio
$1.13M +$80.1K +2,471 +9%

SRPT Hedge Fund Activity: Q4 2015 in Review

151 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q4 2015, worth a combined $1.1B — up 23% from $891M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SRPT positions and 19 closed out — a net gain of 3 holders — while 67 added to existing stakes and 38 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $47.5M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $31.4M.

  • 151 institutional investors held Sarepta Therapeutics (SRPT) as of Q4 2015, up from 149 in Q3 2015.
  • Funds reported $1.1B of Sarepta Therapeutics stock for Q4 2015, up 23% quarter-over-quarter.
  • 22 funds opened new Sarepta Therapeutics positions in Q4 2015 and 19 closed out, a net change of +3 holders.
  • The largest Sarepta Therapeutics buyer in Q4 2015 was Point72 Asset Management, an estimated $47.5M added.
  • The largest Sarepta Therapeutics seller in Q4 2015 was Columbia Wanger Asset Management, an estimated $31.4M sold.

Based on aggregated 13F filings for Q4 2015.